Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pinto PBA"'
Autor:
Verma SK; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Ana-Sosa-Batiz F; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Timis J; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Shafee N; Synbal Inc., 1759 Yorktown Rd., San Mateo, CA, 94402, USA., Maule E; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Pinto PBA; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Conner C; Synbal Inc., 1759 Yorktown Rd., San Mateo, CA, 94402, USA., Valentine KM; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Cowley DO; TransViragen Inc., 109 Mason Farm Road, Chapel Hill, NC, 27599, USA., Miller R; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Elong Ngono A; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Tran L; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Varghese K; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Dos Santos Alves RP; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Hastie KM; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Saphire EO; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Webb DR; Synbal Inc., 1759 Yorktown Rd., San Mateo, CA, 94402, USA., Jarnagin K; Synbal Inc., 1759 Yorktown Rd., San Mateo, CA, 94402, USA., Kim K; Histopathology Core Facility, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA. Electronic address: kenneth@lji.org., Shresta S; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA; Division of Host-Microbe Systems and Therapeutics, Department of Pediatrics, UC San Diego School of Medicine, La Jolla, CA, 92037, USA. Electronic address: sujan@lji.org.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Oct; Vol. 108, pp. 105361. Date of Electronic Publication: 2024 Sep 30.
Autor:
Dos Santos Alves RP; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Timis J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Miller R; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Valentine K; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Pinto PBA; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Gonzalez A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Regla-Nava JA; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.; Department of Microbiology and Pathology, University Center for Health Science (CUCS), University of Guadalajara, Guadalajara, 44340, Mexico., Maule E; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Nguyen MN; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Shafee N; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Landeras-Bueno S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Olmedillas E; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Laffey B; Microscopy and Histology Core Facility, La Jolla Institute for Immunology, La Jolla, CA, USA., Dobaczewska K; Microscopy and Histology Core Facility, La Jolla Institute for Immunology, La Jolla, CA, USA., Mikulski Z; Microscopy and Histology Core Facility, La Jolla Institute for Immunology, La Jolla, CA, USA., McArdle S; Microscopy and Histology Core Facility, La Jolla Institute for Immunology, La Jolla, CA, USA., Leist SR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kim K; Histopathology Core Facility, La Jolla Institute for Immunology, La Jolla, CA, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Ollmann Saphire E; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA., Elong Ngono A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA. aelong@lji.org., Shresta S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA. sujan@lji.org.
Publikováno v:
Nature communications [Nat Commun] 2024 Jan 26; Vol. 15 (1), pp. 787. Date of Electronic Publication: 2024 Jan 26.
Autor:
Pinto PBA; Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil., Barros TAC; Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil., Lima LM; Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil., Pacheco AR; Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil., Assis ML; Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil., Pereira BAS; Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil., Gonçalves AJS; Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil., Azevedo AS; Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil., Neves-Ferreira AGC; Laboratory of Toxinology, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil., Costa SM; Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil., Alves AMB; Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Publikováno v:
Viruses [Viruses] 2022 Jun 30; Vol. 14 (7). Date of Electronic Publication: 2022 Jun 30.
Autor:
Alves AMB; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Costa SM; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Pinto PBA; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
Publikováno v:
Frontiers in medical technology [Front Med Technol] 2021 Apr 12; Vol. 3, pp. 640964. Date of Electronic Publication: 2021 Apr 12 (Print Publication: 2021).
Autor:
Pinto PBA; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Assis ML; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Vallochi AL; Laboratory of Immunopharmacology, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Pacheco AR; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Lima LM; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Quaresma KRL; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Pereira BAS; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Costa SM; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Alves AMB; Laboratory of Biotechnology and Physiology of Viral Infections, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 Jul 03; Vol. 10, pp. 1522. Date of Electronic Publication: 2019 Jul 03 (Print Publication: 2019).